Paul L Berns's Net Worth

$134 Million

Estimate Recalculated Sep 16, 2024 03:06PM EST

Who is Paul L Berns?

Paul L Berns has an estimated net worth of $134 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals Inc, JAZZ PHARMACEUTICALS INC, EQRx, Inc., Menlo Therapeutics Inc., Unity Biotechnology, Inc., Cellectar Biosciences, Inc., XENOPORT INC, ALLOS THERAPEUTICS INC, Neumora Therapeutics, Inc., and BONE CARE INTERNATIONAL INC.

SEC CIK

Paul L Berns's CIK is 0001202769

Past Insider Trading and Trends

2015 was Paul L Berns's most active year for acquiring shares with 15 total transactions. Paul L Berns's most active month to acquire stocks was the month of July. 2015 was Paul L Berns's most active year for disposing of shares, totalling 29 transactions. Paul L Berns's most active month to dispose stocks was the month of February. 2014 saw Paul L Berns paying a total of $7,423,500.00 for 779,950 shares, this is the most they've acquired in one year. In 2016 Paul L Berns cashed out on 856,339 shares for a total of $25,590,187.08, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anacor Pharmaceuticals, Inc. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-231.31K
$99.25
-$22,957,616.75
0
Jun 24
Form 4
-14.00%
-37.50K
$60.31
-$2,261,615.49
230.31K
Scheduled
Mar 22
Form 4
+5.76%
14.58K
—
—
267.81K
Feb 3
Form 4
-0.99%
-2.53K
$112.35
-$284,581.99
252.23K
Scheduled
Jan 4
Form 4
—
0
$63.63
-$2,145,186.91
254.76K
Scheduled
Dec 11
Form 4
—
0
$72.51
-$2,692,887.88
254.76K
Scheduled
Sep 15
Form 4
—
0
$71.90
-$2,671,678.05
254.76K
Scheduled
Aug 13
Form 4
-17.81%
-55.00K
$63.64
-$3,181,820.49
253.76K
Scheduled
Mar 20 - Apr 27
Form 4
-10.83%
-37.50K
$56.07
-$2,102,643.75
308.76K
Scheduled
Mar 19
Form 4
+6.21%
20.26K
—
—
346.26K
Feb 3
Form 4
-7.14%
-25.00K
$30.82
-$770,505.00
325K
Scheduled
Dec 26
Form 4
∞
350K
$21.21
$7,423,500.00
350K
Mar 21
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 30
Form 3
—
0
—
—
0
No matching records found

Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $107.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.89%
-1.45K
$154.00
-$223,300.00
8.29K
Aug 5
Form 4
—
0
$150.42
-$705,603.65
9.74K
Scheduled
Nov 2 - Nov 4
Form 4
+22.27%
1.77K
$125.87
-$117,185.44
9.74K
Aug 6 - Aug 7
Form 4
+17.63%
1.19K
$135.65
-$98,481.10
7.97K
Aug 8 - Aug 9
Form 4
+14.06%
835
$176.61
-$116,563.19
6.77K
Aug 9 - Aug 10
Form 4
+13.43%
703
$142.37
-$94,247.63
5.94K
Aug 10 - Aug 11
Form 4
-10.79%
-633.00
$136.45
-$86,372.85
5.23K
Aug 15
Form 4
+30.32%
1.36K
—
—
5.87K
Aug 11
Form 4/A
—
0
—
—
0
Form 4
+10.02%
509
$180.00
-$144,177.51
5.59K
Aug 7 - Aug 10
Form 4
-21.40%
-1.09K
$133.15
-$144,734.05
3.99K
Aug 12
Form 4
+48.10%
1.65K
—
—
5.08K
Aug 7
Form 4
-23.78%
-1.07K
$81.86
-$87,590.20
3.43K
Aug 13
Form 4
+100.00%
2.25K
—
—
4.5K
Aug 8
Form 4
∞
2.25K
—
—
2.25K
Aug 9
Form 4
-100.00%
-39.20K
$49.56
-$1,942,752.00
0
Mar 9
Form 4
∞
39.2K
—
—
39.2K
Jan 18
Form 3
—
0
—
—
0
Form 4
-100.00%
-39.20K
—
—
0
Jan 18
Form 4
∞
39.2K
$31.28
$70.00
39.2K
Jan 11 - Jan 11
Form 4
—
0
—
—
0
Nov 4
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Aug 25
Form 4
—
0
—
—
0
Jun 4
Form 3
—
0
—
—
0
No matching records found

EQRx, Inc. (EQRX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-627.00K
—
—
0
Nov 9
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Sep 30
Form 4
∞
627K
—
—
627K
Dec 17
Form 3
—
0
—
—
0
No matching records found

Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

Unity Biotechnology, Inc. (UBX) Snapshot price: $1.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jun 20
Form 4
∞
3.26K
—
—
3.26K
May 7
Form 3
—
0
—
—
0
No matching records found